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Abstract. The magnitude of antibody responses varies across the individual proteins that constitute any given mi-
croorganism, both in the context of natural infection and vaccination with attenuated or inactivated pathogens. The
protein-speciﬁc factors underlying this variability are poorly understood. In 267 individuals exposed to intense seasonal
malaria, we examined the relationship between immunoglobulin G (IgG) responses to 861 Plasmodium falciparum pro-
teins and speciﬁc features of these proteins, including their subcellular location, relative abundance, degree of poly-
morphism, andwhether they are predicted to have human orthologs.We found that IgG reactivity was signiﬁcantly higher
to extracellular and plasmamembrane proteins and also correlated positively with both protein abundance and degree of
protein polymorphism. Conversely, IgG reactivity was signiﬁcantly lower to proteins predicted to have human orthologs.
These ﬁndingsprovide insight intoprotein-speciﬁc factors that are associatedwith variability in themagnitudeof antibody
responses to natural P. falciparum infection—data that could inform vaccine strategies to optimize antibody-mediated
immunity as well as the selection of antigens for sero-diagnostic purposes.
INTRODUCTION
In the context of natural infections as well as vaccination
withattenuatedor inactivatedmicroorganisms, themagnitude
of antibody responses varies across the individual antigens
that constitute the microorganism. It is unclear whether the
heterogeneity in antibody responses is associated with spe-
ciﬁc features of proteins, such as subcellular location, relative
abundance,molecular weight (MW), degree of polymorphism,
or whether a protein is predicted to have human orthologs. In
the case of antibody responses to malaria, until recently,
technical limitations, such as low-throughput serological as-
says and traditional cloning and protein expression methods
that made < 0.5% of Plasmodium falciparum proteins avail-
able for analysis1 precluded systematic, unbiased analyses of
the relationship between protein-speciﬁc features and host
antibody responses. Indeed, most prior efforts to understand
themechanisms underlying immunodominance have focused
on differences in immune responses between epitopes within
a given antigen rather than differences between antigens of a
given microorganism.2 For example, prior studies have
examined the link between immunodominance and antigen-
B cell receptor binding afﬁnity,3 epitope accessibility, hydrophi-
licity, andmobility,4 aswell asvariation inantigenprocessingand
presentation to CD4+ T cells via peptide-MHC II complexes.5–10
While these features of B- and T-cell epitopes clearly inﬂu-
ence immunodominance at the single antigen level, only re-
cently has the genomics-based technology become available
to examine protein-speciﬁc factors that underlie variability in
antibody responses across the entire proteome of important
pathogens. For example, a study inwhich serumsamples from
subjects with tuberculosis were probed against a protein
microarray containing the full Mycobacterium tuberculosis
proteome (4,099 proteins) showed enrichment of antibody
responses directed against secreted M. tuberculosis pro-
teins.11 Similarly, a study that probed serum samples from
subjects with brucellosis against a protein microarray with
3,046 Brucella melitensis proteins showed enrichment of an-
tibodies targeting secreted and membrane-associated pro-
teins.12 Similar analyses have yet to be applied to eukaryotic
pathogens, such as Plasmodium parasites, the causative
agents of malaria. This is particularly relevant to P. falciparum
malaria, as several vaccine strategies involve whole para-
sites that are either radiation attenuated,13 genetically
attenuated,14,15 or given under chemoprophylaxis.16 Indeed,
recent studies reveal heterogeneity in the magnitude of anti-
body responses to individual proteins that constitute these
whole organism vaccine candidates.13,16 Nonetheless, there
have been no published systematic attempts to understand
the protein speciﬁc factors underlying the variability in anti-
body responses to P. falciparum. Here, we took advantage
of P. falciparum protein microarray technology,17 publicly
available protein annotation databases,18,19 and a cohort study
conducted in an area of intense seasonal malaria to examine
protein speciﬁc factors associated with antibody immunodo-
minance in the context of natural P. falciparum infection.
MATERIALS AND METHODS
Ethical approval. This study was approved by the Ethics
Committee of the Faculty of Medicine, Pharmacy and
Odonto-Stomatology, University of Bamako, Mali, and the
Institutional Review Board at the National Institute of Allergy
and Infectious Diseases, National Institutes of Health (NIAID
protocol 11-I-N126). Plasma from anonymous healthy U.S.
adult volunteers was obtained from the General Clinical
Research Center at the University of California, Irvine (UCI
IRB protocol 2007-5896). A written informed consent was
obtained from adult participants and parents or legal
guardians of participating children.
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Study participants. This study was conducted in
Kalifabougou, Mali, where intense P. falciparum trans-
mission occurs from June through December each year,
whereas transmission is negligible during the dry season from
January through May. A detailed description of the study site
and cohort design has been published elsewhere.20 At the end
of thedry season inMay2011,weenrolled695healthy subjects
aged 3months to 25years in this ongoing cohort (Figure 1). The
disproportionate sample size of age groups reﬂects the design
of this study that focuses on older children as they transition
from malaria susceptibility to immunity. Exclusion criteria at
enrollment included a hemoglobin level < 7 g/dL, axillary
temperature ³ 37.5C, acute systemic illness, underlying
chronic disease, use of antimalarial or immunosuppressive
medications in the past 30 days, or pregnancy. For this analysis,
we focused on an age-stratiﬁed subset of subjects from the
cohort (N = 267) with ages ranging 3 months to 25 years of age
whose ﬁngerprick blood sampleswere negative forPlasmodium
by polymerase chain reaction (PCR) at enrollment. Of these 267
subjects, 229were also negative forPlasmodium byPCRafter 1
year at the end of the dry season in May 2012. Paired plasma
samples collected from subjects at these two timepoints (May
2011 and May 2012) were analyzed by protein microarray.
Experimental design and statistical rationale. A total of
515 experimental plasma samples (267 from May 2011, 234
from May 2012, and 14 replicates) were probed by protein
microarray. In addition, 14 experimental replicates were also
probed (2.8% of the experimental samples). To conﬁrm re-
producibility of the array, a total of 20 reference plasma rep-
licates from Papua New Guinea were also probed (two
replicates for every 96 samples). To minimize confounding
from potential nuisance effects from array printing (such as a
pad, slide, or batch printing effect) or assay performance
technique during each run, the assay sequence of experi-
mental samples and experimental replicates was randomized
to evenly distribute samples by timepoint, age group, and sex
across the sequence of proteinmicroarray probing. To assess
speciﬁcity of the microarray to P. falciparum infection, we in-
cluded eleven negative control samples from malaria naive
adults 20 to 59 years of age residing in Orange County, CA
(with 11 probed in an earlier experiment with the same printed
batch of microarrays, and one duplicate embedded within ex-
perimental samples). Power and sample size analysis was not
used in this study as the samples are from a previously estab-
lished protocol as described previously, and the maximum
number of samples for the relevant age groups was used.
Plasma samples. Blood samples were drawn by veni-
puncture into tubes containing sodium citrate (Vacutainer
CPT; BD Biosciences, San Jose, CA), stored in iceboxes be-
low room temperature, and then transported to the laboratory
within 12 hours. Plasma was separated by centrifugation and
stored at −80C.
Detection of P. falciparum infections. A two-step nested
PCRwas performed to amplifyPlasmodiumDNAdirectly from
dried blood spots on ﬁlter paper. Detailed methods for the
detection of P. falciparum by PCR are described elsewhere.20
Antibody proﬁling by protein microarray. The Pf1000
protein microarray (Antigen Discovery, Inc., Irvine, CA) con-
taining 1,087 proteins representing∼23%of theP. falciparum
proteomewasused toprobeplasmasamples.Proteins <1,014
amino acids (N = 269) were expressed as full-length proteins,
whereasproteins>1,014aminoacids (N=818)wereexpressed
as polypeptide fragments. For simplicity, “microarray proteins”
refers to both full-length proteins and polypeptides. The 1,087
microarray proteins were chosen from a larger previously
constructed 4,528 protein array (Pf4528) representing 60% of
the proteome in a downselection process. Sera from 20
P. falciparum-exposed adults each in Papua New Guinea,
Kenya, and Mali, and 10 malaria-naive adults in the United
States were probed with this microarray. Proteins were identi-
ﬁed and placed into tiers by seroreactivity in: 1) all countries,
2) > 50% of countries, 3) < 50% of countries, and 4) proteins
of signiﬁcance fromother analyses. Signiﬁcant proteinswere
consecutively selected starting from the ﬁrst tier until 1,087
proteins/polypeptides were identiﬁed.
The downselected proteins were expressed in a process21
that consists of PCR ampliﬁcation of corresponding open
reading frames of the 3D7 strain of P. falciparum, in vivo
recombination cloning into an Escherichia coli vector, in vitro
FIGURE 1. Study design ﬂow chart. Sequence of selection events
made to arrive at 234 study subjects.
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transcription/translation, and printing of the protein product
onto nitrocellulose-coated glass slides. Each slide was com-
posed of eight separate microarrays (pads) against which one
plasma sample was probed. Microarray probing is described
in detail elsewhere,17 which in summary consisted of applying
each 1:200 diluted individual plasma sample to one micro-
array, followed by a biotin-conjugated goat anti-human im-
munoglobulin G (IgG) secondary antibody and ﬂuorescently
labeled streptavidin conjugate. IgG reactivity was quantiﬁed
by a microarray scanner as a unitless relative signal intensity.
Measurement of femtomolar abundance of merozoite
protein. For investigation of the relationship between
protein abundance and IgG reactivity, wild-type merozo-
ites were obtained from the rupture of continuously cultured
schizonts through cell-sieving and collection and prepared
for liquid chromatography/mass spectrometry (LC/MSE)
analysis described elsewhere.22 In brief, 4 × 108 merozoites
were suspended in 50 mM ammonium bicarbonate (pH 8.5)
with 0.06% RapiGest™ (Waters Corp., Milford, MA). Disul-
ﬁde bonds in merozoite protein were reduced with 10 mM
dithiothreitol at 60C for 30minutes, followedby alkylation of
free cysteine residues with 30 mM iodoacetamide at room
temperature for 30 minutes, and then digested overnight
with trypsin at 37C. A two-dimensional reverse phase
chromatograph with an online Synapt G2-S mass spec-
trometer (Waters Corp.) measured femtomolar abundance.
Data analysis. R statistical software (version 3.2.3) was
used to perform data analysis (Figure 2). Unless otherwise
speciﬁed, IgG reactivity refers to normalized mean IgG re-
activity in all study subjects inMay of 2011. A sinh−1 transform
(f(x) = sinh−1(a + bx), a = 1, b = 50) was used to transform
measured IgG reactivity values for 1,087 antigens into a nor-
malized distribution. To account for cross reactivity to back-
ground protein (i.e., protein byproducts of the expression
system), mean NoDNA reactivity (represented by spots with-
out DNA template in the plasmid vector) was subtracted from
these transformed values, which were then scaled for nui-
sance variables speciﬁc to theproteinmicroarray (batch, slide,
and pad effects) using robust linear model normalization.23
Negative values (indicating reactivity below that of the nega-
tive control samples without DNA template) were set to zero.
Reactivity of plasma from naive individuals to malaria protein
would suggest the presence of non-P. falciparum speciﬁc an-
tibodies. To adjust for potential nonmalaria speciﬁc antibodies
found in both US naive and experimental plasma samples,
mean nuisance scaled reactivity values of 11 US naive adults
were subtracted frommean nuisance scaled values for the 267
subjects for each protein. We called this adjusted mean re-
activity as normalized mean IgG reactivity, which was used as
the response variable in subsequent analysis.
Data for each proteomic feature were obtained through
publicly available annotations18,19 with the exception of mer-
ozoite protein abundance (ex vivo molar amounts), as de-
scribed earlier. Microarray proteins were mapped to Gene
Ontology Terms by cellular component using the Princeton
Generic Gene Ontology Term Mapper24,25 referencing the
GeneDB gene association ﬁle (April 1, 2015) for P. falciparum
strain 3D7,19 then mapped to their respective highest level
parent terms: intracellular, plasma membrane, and extracel-
lular. The intracellular region was deﬁned as any component
within but not including the plasma membrane; the plasma
membrane as the phospholipid bilayer and associated
proteins separating the cell from its external environment; and
the extracellular region as the space external to the parasite
plasmamembrane including the host cell environment outside
an intracellular parasite. Presence of human orthologs was
determined through the orthoMCL algorithm which clusters
proteins into ortholog groups by BLAST similarity.26 Each
FIGURE 2. Data normalization ﬂow chart. Sequence of steps made
to normalize microarray reactivity to scale for background signal,
nuisance variables, and adjustment for non-Plasmodium falciparum
speciﬁc antibody binding.
PREDICTORS OF MALARIA ANTIBODY RESPONSE 59
proteomic feature was treated as a factor (if categorical) or
covariate (if continuous) in a simple linear model with nor-
malized mean reactivity for each protein as the dependent
variable. Continuous proteomic features were also treated as
factors by categorizing values in amixture of densitiesmodel (R
packagemixtools27) with two normal distributions with a cutoff
of two standard deviations above themean of the lower normal
distribution. Comparisons between factor levels were made
using single-step adjusted contrasts from a linear model, and
for continuous covariates, a simple regression line was esti-
mated. Comparisons were also made for each factor by strat-
ifying subjects into age group, from which normalized mean
reactivity was compared using single-step adjusted contrasts
froma linearmixed-effects statisticalmodel (Rpackage lme428)
with each subject as a random effect.
To identify collinearity, we performed Pearson χ2 testing for
each possible pairing of proteomic features treated as factors.
We then constructed multiple linear regression models using all
signiﬁcant proteomic features and interaction variables for fac-
tors previously determined not to be independent by Pearson χ2
testing using May 2011 data as a training set. Bidirectional
stepwise regression was performed to determine relevant
factors/covariates with nonrelevant factors/covariates re-
moved. The ﬁnal models were validated usingMay 2012 data.
RESULTS
IgG reactivity across individual P. falciparum proteins is
markedly heterogeneous. Characteristics of 267 study
subjects are shown inTable 1.Of these267subjects, 229were
also negative forPlasmodium by PCR 1 year later at the end of
TABLE 1
Baseline characteristics of all 267 study participants by age group
Age group
Characteristic < 2 2–4 5–7 8–10 11–17 ³ 18 All
Female sex 33 20 29 36 6 7 131
Hgb AC 3 5 4 13 1 1 27
Hgb AS 6 6 6 10 1 2 31
Hgb SC 0 0 0 1 0 0 1
Febrile malaria* 33 41 40 46 7 4 171
Total 67 54 51 74 11 11 229
* Febrile malaria deﬁned as axillary temperature of 37.5C, ³ 2,500 asexual parasites/μL of
blood, and no other cause of fever discernible by physical exam.
FIGURE 3. The level of Immunoglobulin G (IgG) reactivity to individual Plasmodium falciparum proteins is heterogeneous. (A) Histogram of
normalized mean IgG reactivity to 1,087 P. falciparummicroarray proteins from plasma collected in May 2011 from 267 subjects in Kalifabougou,
Mali, in increments of 0.02. Positive normalizedmean IgG reactivities ﬁt a gammadistribution (k = 1.338, standard error = 0.052, β = 4.236, standard
error = 0.1981) with predicted values shown by a dashed line. (B) Histogram for plasma collected in May 2012 from 229 subjects with ﬁtting of
positive normalized mean IgG reactivities to a gamma distribution (k = 1.343, standard error = 0.0521, β = 4.246, standard error = 0.1987).
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the dry season in May 2012. The antibody proﬁles of plasma
samples collected from subjects at these two timepoints (May
2011 and May 2012) were analyzed by a protein microarray con-
taining 1,087 P. falciparum proteins. This analysis revealed that
IgG reactivity levelsaremarkedlyheterogeneousacross individual
P. falciparum proteins—ranging from nonspeciﬁc reactivity at the
level of US naive samples (0) to two orders of magnitude above
thesenegative controls (2.0). A similar patternwasobserved in the
same cohort 1 year later in May 2012 (Figure 3).
IgG reactivity to extracellular and plasma membrane
proteins is higher than IgG reactivity to intracellular proteins.
We ﬁrst examined the relationship between IgG reactivity and
the subcellular location of the proteins on the microarray. Of the
861 full-length proteins represented on the microarray, 735
mapped to generic cellular component Gene Ontology Terms
(locations at the level of subcellular structures and macromo-
lecular complexes found across all domains of life), whereas 608
mapped exclusively to their respective highest level parent
terms: intracellular, plasma membrane, and extracellular. Of
note, no proteins mapped exclusively to the parasitophorous
vacuolar space or membrane. We found that IgG reactivity to
extracellular and plasma membrane proteins was signiﬁcantly
higher than IgG reactivity to intracellular proteins (P < 0.001;
Figure 4A), a ﬁnding that remained signiﬁcant within each of the
age strata (P < 0.001; Figure 4B).
IgG reactivity correlates with protein abundance. Next,
we examined the relationship between IgG reactivity and the
abundance of P. falciparummerozoite proteins. To do so, we
used MS to determine the quantity of proteins expressed by
merozoites puriﬁed from culture. On the microarray, 281
proteins/polypeptides represented 251 of the full-length
merozoite proteins for which MS data was available. We ob-
served a positive correlation between IgG reactivity and
merozoite protein abundance (P < 0.001; Figure 5A). We then
classiﬁed the same 281 proteins into high abundance (N = 68)
and low abundance proteins (N = 213) by ﬁtting a mixture of
densitiesmodel and found that IgG reactivity was signiﬁcantly
greater against more highly abundant proteins (P < 0.01;
Figure 5B)—a pattern that was consistently observed within
each of the age strata (P < 0.001; Figure 5C).
FIGURE 4. Immunoglobulin G (IgG) reactivity to extracellular and plasmamembrane proteins is higher than IgG reactivity to intracellular proteins.
(A) Mean IgG reactivities to individual Plasmodium falciparum proteins classiﬁed by Gene Ontology parent cellular component (intracellular,
extracellular, and plasma membrane) in plasma samples of 267 subjects. Vertical bars represent standard deviation of mean of reactivities (bold
horizontal line). (B) Mean IgG reactivities to individual P. falciparum proteins classiﬁed by Gene Ontology parent cellular component in plasma
samples of 267 subjects stratiﬁed by age. All data are normalized to mean IgG reactivity of U.S. adults. Multiple single-step adjusted comparisons
were made from a linear model in (A) and from a linear mixed-effects model in (B). ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05, ns = not
signiﬁcant.
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Protein size correlates inversely with IgG reactivity.
Next, we investigated the relationship between IgG reactivity
and the MW of proteins on the microarray. Because the
microarray contains both full-length proteins and polypep-
tides (in the case of larger proteins), we examined the re-
lationship between IgG reactivity and the MW of each protein
represented on the microarray. We observed an inverse
correlation between IgG reactivity and MW (P < 0.001;
Supplemental Figure 1A).We then classiﬁed proteins into high
(N = 482) and lowMW (N = 604) by ﬁtting amixture of densities
model. We found that IgG reactivity to high MW proteins was
signiﬁcantly lower than IgG reactivity to low MW proteins (P <
0.01; Supplemental Figure 1B), a pattern that was again
apparent across the age strata (P < 0.001; Supplemental
Figure 1C).
IgG reactivity to proteins with human orthologs is
signiﬁcantly lower. Next, we tested the hypothesis that IgG
responses are lower to P. falciparum proteins predicted to
have human orthologs, consistent with the deletion of
autoreactive B- and T-lymphocyte clones. Using the orthoMCL
algorithm, which clusters proteins into ortholog groups by
BLAST similarity,26 we identiﬁed 256 full-length P. falciparum
proteins (represented by 320microarray proteins) with predicted
human orthologs. Consistent with our hypothesis, IgG reactivity
to P. falciparum proteins with predicted human orthologs was
signiﬁcantly lower than IgG reactivity to those without predicted
human orthologs (P < 0.001; Figure 6A), a ﬁnding also observed
across the age strata (P < 0.001; Figure 6B).
Degree of polymorphism correlates with IgG reactivity.
We examined the relationship between IgG reactivity and the
degree of polymorphism of P. falciparum proteins. For each
protein or polypeptide on the microarray we determined the
number of single nucleotide polymorphism (SNPs)/kb in the
corresponding gene or gene fragment, respectively.18 We
observed a positive correlation between IgG reactivity and
SNPs/kb (P < 0.001; Figure 7A). Next, we used a mixture of
densities model to classify microarray proteins as conserved
(N = 967) or polymorphic (N = 87) and found that average IgG
reactivity is higher to polymorphic proteins (P < 0.001;
Figure 7B), a pattern consistent across age groups (P < 0.001;
Figure 7C). As expected, IgG reactivity only varied with
the number of nonsynonymous SNPs/kb (P < 0.001;
Supplemental Figure 2B), whereas no correlation was found
between IgG reactivity and the number of synonymous
SNPs/kb (P < 0.87; Supplemental Figure 2A).
We then focused on the antibody response to P. falciparum
erythrocyte membrane protein 1 (PfEMP1). Each parasite
genome contains ∼60 var genes encoding the highly poly-
morphic PfEMP1s that are clonally expressed by the parasite
and transported to the host erythrocyte plasma membrane.29
PfEMP1s bind to ligands on endothelial cells to sequester
infected erythrocytes in the venules of various tissues to es-
cape splenic clearance. Eight polypeptides (with a mean of
107.1 SNPs/kb 95% conﬁdence interval [CI]: 77.6–136.6) on
the microarray correspond to exon 2 of PfEMP1, which en-
codes the relatively conserved intraerythrocytic Acidic Ter-
minal Segment (ATS), whereas 19 polypeptides (with a mean
of 235.9 SNPs/kb 95% CI: 206.8–265.0) represent the highly
polymorphic extraerythrocytic domains expressed from exon
1. In contrast to the correlation observed between IgG re-
activity and SNPs/kb for all proteins on the array (Figure 7A),
IgG reactivity was higher against the conserved ATS domains
compared with the polymorphic extraerythrocytic domains
(P < 0.001; Figure 7D).
Polymorphism in plasma membrane proteins predicts
IgG reactivity in multiple regression analysis. Finally, we
constructed multiple linear regression models to identify
proteomic variables that are independently associated with
FIGURE 5. Abundance of merozoite proteins correlates with Immunoglobulin G (IgG) reactivity (A) Scatterplot showing mean IgG reactivity (in
proteinmicroarray data for 267 subjects) vs.mean abundance in femtomoles bymass spectrometry for 281merozoite proteins (dots). (B) Mean IgG
reactivities to low abundance (N = 213) vs. high abundance proteins (N = 68). Vertical bars represent standard deviation from mean. (C) Mean IgG
reactivities to low abundance (N = 213) vs. high abundance proteins (N = 68) stratiﬁed by age. All data are normalized tomean IgG reactivity of U.S.
adults. Scatterplot in (A) ﬁtted to simple linear regressionmodel; comparisons in (B) were made using a linear model and in (C) from a linear mixed-
effects model. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05, ns = not signiﬁcant.
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IgG reactivity. Pearson χ2 testing for independence between
factors demonstrated signiﬁcant interactions between the
following variables: polymorphism*subcellular location (P <
0.001), polymorphism*human orthologs (P < 0.001), sub-
cellular location*humanorthologs (P<0.001), andMW*human
orthologs (P < 0.05) (Table 2). Protein abundance as a variable
was excluded from the model because only data from the
merozoite stage of the parasite life cycle was avail-
able. Bidirectional stepwise regression indicated all four
proteomic variables and three of the interaction terms
(polymorphisms*subcellular location, polymorphisms*human
orthologs, and MW*human orthologs) should be included in the
model. Given that subcellular location had a limited number of
exclusively assigned antigens (608 of 1,087, or 56%) and the
implied limitation of signiﬁcant interaction of subcellular location
to just polymorphisms by stepwise regression, we constructed
two models: the ﬁrst considering only subcellular location and
polymorphisms as independent variables and the second with-
out subcellular location but with all other variables and their
signiﬁcant interactions. In the ﬁnal model, with subcellular
location and polymorphisms (R2 = 0.199), IgG reactivity signiﬁ-
cantly increased with additional SNPs/kb among proteins lo-
cated in the plasma membrane (P < 0.0001) but no
significant relationship was noted for other subcellular locations
(Supplemental Figure 3). Of note, no plasmamembrane proteins
had SNPs/kb greater than 120. In the second model without
subcellular location, we noted a low R2 of 0.0685 suggesting a
minimal role of degree of polymorphism, presence of human
ortholog, or MW as determinants of IgG reactivity. We validated
this model with protein microarray data generated from the
same cohort (N = 229 subjects) using plasma samples col-
lected 1 year later in May 2012, and again noted a signiﬁcant
increase in IgG reactivity with additional SNPs/kb among
plasmamembrane proteins as well as similarR2 values (R2 =
0.172 in ﬁrst model, 0.0572 in second model, Table 3).
DISCUSSION
Here, we sought to gain insight into protein-speciﬁc fac-
tors that underlie heterogeneity in the magnitude of IgG
FIGURE 6. Immunoglobulin G (IgG) reactivity is lower to Plasmodium falciparum proteins with human orthologs. (A) Mean IgG reactivities to P.
falciparum proteins with (N = 320) or without (N = 767) human orthologs. Vertical bars represent standard deviation from mean. (B) Mean IgG
reactivities to P. falciparum proteins with (N = 320) or without (N = 767) human orthologs stratiﬁed by age. All data are normalized to mean IgG
reactivity of U.S. adults. Comparisons in (A) were made using a linear model and in (B) a linear mixed-effects model. ****P < 0.0001, ***P < 0.001,
**P < 0.01, *P < 0.05, ns = not signiﬁcant.
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responses to P. falciparum antigens in the context of natural
infection—a study made possible by genomics-based
technology that allows antibody responses to be interro-
gated across the entire or large portions of the proteome of
important pathogens. When not accounting for interactions,
we observed that IgG responses were higher to extracellular
and plasma membrane proteins and correlated positively
with both protein abundance and degree of protein poly-
morphism. By contrast, IgG reactivity was signiﬁcantly lower
to proteins predicted to have human orthologs and corre-
lated inversely with protein MW.
The observation that IgG responses are higher to extracel-
lular and plasma membrane P. falciparum proteins is consis-
tent with recent studies using protein microarrays to proﬁle
IgG responses in individuals with tuberculosis11 or brucello-
sis.12 The link between the magnitude of antibody responses
and protein location is also consistent with experimental data
in mouse models. For example, surface display of Plasmo-
dium antigen on Salmonella typhimurium induced higher an-
tibody responses than periplasmic expression of the same
antigen.30 Similarly, B cells demonstrated a greater ability to
respond to help from inﬂuenza-speciﬁc T-cells when viral
antigens were external versus internal.31
The ﬁnding that IgG responses to P. falciparum merozoite
proteins correlated with the abundance of the same merozoite
proteins in vitro is consistent with the same brucellosis study,
which showed that immunodominant antigens are enrichedwith
proteins that are expressed at higher levels in vitro.12 However,
thisﬁndingshouldbe interpretedwithcautionasouranalysiswas
restricted to merozoites. Moreover, merozoite protein abun-
dance in vitro may not accurately reﬂect in vivo abundance.
We observed that IgG reactivity was higher to polymor-
phic proteins (greater number of nonsynonymous SNPs/kb).
However, multivariate regression analysis suggests that the re-
lationship between IgG reactivity and protein polymorphism is
confounded by the ﬁnding that plasma membrane and extra-
cellular proteins tend to be more polymorphic. In other words,
higher IgG responses to extracellular and plasma membrane
proteins may be driven by accessibility (as suggested by the
murine studies noted previously), and presumably this same
antibody response drives extracellular/plasma membrane pro-
teins to become polymorphic by impacting parasite ﬁtness.
FIGURE 7. ImmunoglobulinG (IgG) reactivity correlateswith degreeof protein polymorphism. (A) Scatterplot showingmean IgG reactivity (protein
microarray data for 267 subjects) vs. single nucleotide polymorphism (SNPs)/kb for each of 1054 proteins/polypeptides (dots). (B) Mean IgG
reactivities to conserved (N=967) vs. polymorphic proteins (N=87). Vertical bars represent standarddeviation frommean. (C) Mean IgG reactivities
to conserved (N = 967) vs. polymorphic proteins (N = 87) stratiﬁed by age. (D) Scatterplot showingmean IgG reactivity to P. falciparum erythrocyte
membraneprotein1s (PfEMP1s) on themicroarray (proteinmicroarraydata for 267subjects) vs. SNPs/kb for eachof thePfEMP1s (dots). All dataare
normalized tomean IgG reactivity ofU.S. adults. Scatterplot in (A) ﬁtted to simple linear regressionmodel; comparisonsof reactivity in (B) weremade
using a linear model, in (C) from a linear mixed-effects model, and in (D) with a Welch Two Sample t test. The SNPs/kb were calculated using both
synonymous and nonsynonymous SNPs. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05, ns = not signiﬁcant.
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This point is highlighted by contrasting IgG responses to
the intra- and extraerythrocyte domains of the var gene-
encoded PfEMP1s. Exon 2 of the var genes encodes the
relatively conserved intraerythrocyte ATS domain, which
anchors PfEMP1 in the erythrocyte membrane,32 whereas
exon 1 encodes the hypervariable domains duffy binding-like
domain (DBL) and cysteine-rich interdomain region (CIDR),
which are expressed on the erythrocyte surface and mediate
sequestration of infected erythrocytes in the host vascula-
ture to avoid splenic clearance. Althoughmore conserved, IgG
reactivity was greater to the intraerythrocyte ATS domain com-
pared with the extraerythrocyte DBL and CIDR domains of the
same protein. That the intraerythrocyte ATS domain is con-
served is consistent with it being accessible to host antibody
responses only after the parasite has completed its 48-hour
cycle of erythrocyte invasion, replication and rupture. This ex-
ample highlights the requirement that antibody responses de-
crease parasite ﬁtness for high degrees of polymorphism to
arise from natural selection and also underscores the lack of
causality between the immunogenicity of a givenprotein and its
degree of polymorphism.
We found that IgG reactivity to P. falciparum proteins with
predicted human orthologs was signiﬁcantly lower than
IgG reactivity to proteins without predicted human ortho-
logs, consistent with the deletion of autoreactive B- and
T-lymphocyte clones in the host. An interesting corollary to
this ﬁnding is the possibility that the host species can lose
the ability to express self-antigens through selective pres-
sure if it results in a gained ability to mount protective anti-
body responses against similar antigens expressed by
pathogens.33
In this analysis, we found that MW correlated inversely with
IgG reactivity. However, this ﬁnding should be interpretedwith
caution as larger proteins may be expressed less efﬁciently in
the E. coli-based cell-free expression system used to con-
struct the protein microarrays.34
In summary, we found that IgG reactivity was signiﬁcantly
higher to extracellular and plasma membrane proteins and
also correlated positively with both protein abundance and
degree of protein polymorphism, although the relationship
between IgG reactivity and polymorphisms may be con-
founded by protein subcellular location. Conversely, IgG
reactivity was signiﬁcantly lower to proteins predicted to
have human orthologs. These ﬁndings provide insight
into protein-speciﬁc factors that are associated with vari-
ability in the magnitude of antibody responses to natural
P. falciparum infection—data that could inform vac-
cine strategies to optimize antibody-mediated immunity
as well as the selection of antigens for sero-diagnostic
purposes.
TABLE 2
Pearson’s χ2 testing for independence
Subcellular location Presence of human ortholog High molecular weight
High degree of polymorphism χ2: 124.6626**** χ2: 19.7439**** χ2: 1.7487
df: 2 df: 1 df: 1
P value: < 2.2e−16 P value: 8.854e−06 P value: 0.186
Subcellular location – χ2: 29.7157**** χ2: 0.26634
df: 2 df: 2
P value: 3.526e−07 P value: 0.8753
Presence of human ortholog – – χ2: 4.0901*
df: 1
P value: 0.04313
****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05.
TABLE 3
Determinants of IgG reactivity in May 2011 and 2012 by multiple regression analysis
Coefﬁcient
May 2011 May 2012
Estimate Pr (> jtj) Estimate Pr (> jtj)
(Intercept) 5.44E−01**** < 2.00E−16 4.53E−01**** < 2.00E−16
Segment SNPs per kb −4.07E−05 9.12E−01 −2.15E−04 4.97E−01
Location [intracellular region] −3.37E−01**** 3.30E−10 −2.81E−01**** 7.57E−10
Location [plasma membrane] −7.70E−01**** 7.47E−12 −6.17E−01**** 1.08E−10
Segment SNPs per kb*location
[intracellular region]
1.46E−03 1.01E−01 1.39E−03 6.75E−02
Segment SNPs per kb*location
[plasma membrane]
1.43E−02**** 3.18E−11 1.13E−02**** 7.75E−10
Multiple R2 0.199 0.172
(Intercept) 2.99E−01**** < 2e−16 2.54E−01**** < 2e−16
Segment SNPs per kb 1.75E−03**** 4.07E−10 1.28E−03**** 7.10E−08
Has ortholog −3.13E−02 4.37E−01 −3.02E−02 3.74E−01
MW −2.67E−07**** 8.58E−08 −2.23E−07**** 1.32E−07
Has ortholog*MW 3.00E−07*** 3.95E−04 2.56E−07*** 3.56E−04
Segment SNPs per kb*has ortholog −1.99E−03* 4.10E−02 −1.46E−03 7.64E−02
Multiple R2 0.0685 0.0572
IgG = immunoglobulin G; MW = molecular weight; SNP = single nucleotide polymorphism. Estimations of coefﬁcients in two multiple regression models of normalized mean IgG reactivity with
covariates of SNPs/kb and subcellular location in the ﬁrst model, and presence of ortholog, molecular weight, and SNPs/kb in linear combination with interaction variables identiﬁed by Pearson χ2
analysis and bidirectional stepwise regression from 267 subjects in May 2011 and 234 of the same subjects in May 2012.
****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05.
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